# FDA Inspection 1310324 - Lawrence Berkeley National Laboratory IRB - February 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/lawrence-berkeley-national-laboratory-irb/54fd4c7e-2ae8-4348-93ff-d0bea447dae6
Source feed: FDA_Inspections

> FDA Inspection 1310324 for Lawrence Berkeley National Laboratory IRB on February 13, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1310324
- Company Name: Lawrence Berkeley National Laboratory IRB
- Inspection Date: 2026-02-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1310324 - 2026-02-13](https://www.keypedia.com/records/fda_inspections/lawrence-berkeley-national-laboratory-irb/bb16e50d-619c-442b-a095-f0bc71088a3f)
- [FDA Inspection 1310324 - 2026-02-13](https://www.keypedia.com/records/fda_inspections/lawrence-berkeley-national-laboratory-irb/5187c66a-8783-4d7d-9f1b-a3d304b4dfc9)
- [FDA Inspection 1310324 - 2026-02-13](https://www.keypedia.com/records/fda_inspections/lawrence-berkeley-national-laboratory-irb/d1407c82-73ae-40cf-8e17-d854e779624a)

Company: https://www.keypedia.com/companies/lawrence-berkeley-national-laboratory-irb/87bcfcfe-7bf8-497e-953b-d9a7b47951da